1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora disease
暂无分享,去创建一个
Kimberly L. Chan | B. Minassian | Hamza Dahshi | Souad Messahel | Jimin Ren | Talon Johnson | Anke Henning | Aparna Panatpur
[1] Chi Wang,et al. In situ microwave fixation provides an instantaneous snapshot of the brain metabolome , 2023, Cell reports methods.
[2] M. Garcia-Gimeno,et al. Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model , 2023, International journal of molecular sciences.
[3] U. Mayor,et al. P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease , 2023, Neurobiology of Disease.
[4] Peixiang Wang,et al. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy , 2022, Disease models & mechanisms.
[5] F. Yu,et al. ATP line splitting in association with reduced intracellular magnesium and pH: a brain 31P MR spectroscopic imaging (MRSI) study of pediatric patients with myelin oligodendrocyte glycoprotein antibody‐associated disorders (MOGADs) , 2022, NMR in biomedicine.
[6] C. Majós,et al. High Myoinositol on Proton MR Spectroscopy Could Be a Potential Signature of Papillary Tumors of the Pineal Region—Case Report of Two Patients , 2022, Brain sciences.
[7] L. Ruhm,et al. Measurement of glucose metabolism in the occipital lobe and frontal cortex after oral administration of [1-13C]glucose at 9.4 T , 2022, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] Kimberly L. Chan,et al. Improved prospective frequency correction for macromolecule‐suppressed GABA editing with metabolite cycling at 3T , 2021, Magnetic resonance in medicine.
[9] E. Gumusgoz,et al. Lafora disease: Current biology and therapeutic approaches. , 2021, Revue neurologique.
[10] K. Holton,et al. Brain concentrations of glutamate and GABA in human epilepsy: A review , 2021, Seizure.
[11] E. Porges,et al. The trajectory of cortical GABA across the lifespan, an individual participant data meta-analysis of edited MRS studies , 2021, eLife.
[12] A. Sherry,et al. 31P‐MRS of the healthy human brain at 7 T detects multiple hexose derivatives of uridine diphosphate glucose , 2021, NMR in biomedicine.
[13] F. Nitschke,et al. Targeting Gys1 with AAV‐SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models , 2021, Neurotherapeutics.
[14] C. Muñoz-Ballester,et al. Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease , 2020, Glia.
[15] Wolfgang Bogner,et al. Contribution of macromolecules to brain 1H MR spectra: Experts' consensus recommendations , 2020, NMR in biomedicine.
[16] Valerie J. Sydnor,et al. A quantitative meta-analysis of brain glutamate metabolites in aging , 2020, Neurobiology of Aging.
[17] N. Zölch,et al. Brain proton magnetic resonance spectroscopy findings in a Beagle dog with genetically confirmed Lafora disease , 2020, Journal of veterinary internal medicine.
[18] M. Hottiger,et al. Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation , 2019, Cells.
[19] Matthew S. Gentry,et al. Targeting pathogenic Lafora bodies in Lafora disease using an antibody-enzyme fusion , 2019, bioRxiv.
[20] David White,et al. Neurochemical changes in the aging brain: A systematic review , 2019, Neuroscience & Biobehavioral Reviews.
[21] Heinrich Lanfermann,et al. Effects of Aging on the Human Brain: A Proton and Phosphorus MR Spectroscopy Study at 3T , 2018, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[22] Kimberly L. Chan,et al. Simultaneous detection of glutathione and lactate using spectral editing at 3 T , 2017, NMR in biomedicine.
[23] P. Bovolenta,et al. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease , 2017, EMBO molecular medicine.
[24] Peter Jezzard,et al. Advanced processing and simulation of MRS data using the FID appliance (FID‐A)—An open source, MATLAB‐based toolkit , 2017, Magnetic resonance in medicine.
[25] Kawaguchi Hirokazu,et al. Detection of glucose in the human brain with 1H MRS at 7 Tesla , 2016, Magnetic resonance in medicine.
[26] C. Muñoz-Ballester,et al. Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease. , 2016, Biochimica et biophysica acta.
[27] Craig R Malloy,et al. 31P‐MRS of healthy human brain: ATP synthesis, metabolite concentrations, pH, and T1 relaxation times , 2015, NMR in biomedicine.
[28] Peter Jezzard,et al. Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain , 2015, Magnetic resonance in medicine.
[29] R. Edden,et al. Gannet: A batch‐processing tool for the quantitative analysis of gamma‐aminobutyric acid–edited MR spectroscopy spectra , 2014, Journal of magnetic resonance imaging : JMRI.
[30] E. Hattingen,et al. Frontal and thalamic changes of GABA concentration indicate dysfunction of thalamofrontal networks in juvenile myoclonic epilepsy , 2014, Epilepsia.
[31] J. Delgado-García,et al. Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease. , 2014, Human molecular genetics.
[32] J. Rothwell,et al. The role of the cerebellum in the pathogenesis of cortical myoclonus , 2014, Movement disorders : official journal of the Movement Disorder Society.
[33] R. Agís-Balboa,et al. Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease , 2014, Molecular Brain.
[34] P. Stanwell,et al. Glutamate and glutamine: a review of in vivo MRS in the human brain , 2013, NMR in biomedicine.
[35] C. Rae. A Guide to the Metabolic Pathways and Function of Metabolites Observed in Human Brain 1H Magnetic Resonance Spectra , 2013, Neurochemical Research.
[36] C. Ackerley,et al. Inhibiting glycogen synthesis prevents lafora disease in a mouse model , 2013, Annals of neurology.
[37] S. Shankar,et al. Neuronatin-mediated Aberrant Calcium Signaling and Endoplasmic Reticulum Stress Underlie Neuropathology in Lafora Disease* , 2013, The Journal of Biological Chemistry.
[38] A. Depaoli-Roach,et al. Glycogen and its metabolism: some new developments and old themes. , 2012, The Biochemical journal.
[39] J. Delgado-García,et al. Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease , 2011, EMBO molecular medicine.
[40] Gülin Öz,et al. Short‐echo, single‐shot, full‐intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: Validation in the cerebellum and brainstem , 2011, Magnetic resonance in medicine.
[41] P. Roach,et al. Genetic Depletion of the Malin E3 Ubiquitin Ligase in Mice Leads to Lafora Bodies and the Accumulation of Insoluble Laforin* , 2010, The Journal of Biological Chemistry.
[42] Federico Zara,et al. Short and long interval cortical inhibition in patients with Unverricht-Lundborg and Lafora body disease , 2010, Epilepsy Research.
[43] C. Ackerley,et al. 22‐YEAR‐OLD GIRL WITH STATUS EPILEPTICUS AND PROGRESSIVE NEUROLOGICAL SYMPTOMS , 2009, Brain pathology.
[44] A. Sakamoto,et al. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy , 2009, Epilepsia.
[45] A. Depaoli-Roach,et al. Abnormal Metabolism of Glycogen Phosphate as a Cause for Lafora Disease* , 2008, Journal of Biological Chemistry.
[46] A. Pichiecchio,et al. Lafora disease: spectroscopy study correlated with neuropsychological findings. , 2008, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[47] A. Delgado-Escueta,et al. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo , 2007, Proceedings of the National Academy of Sciences.
[48] C. Worby,et al. Laforin, a Dual Specificity Phosphatase That Dephosphorylates Complex Carbohydrates* , 2006, Journal of Biological Chemistry.
[49] Jong-Min Lee,et al. Structural Brain Abnormalities in Juvenile Myoclonic Epilepsy Patients: Volumetry and Voxel-Based Morphometry , 2006, Korean journal of radiology.
[50] J. Serratosa,et al. MRI Volumetry and Proton MR Spectroscopy of the Brain in Lafora Disease , 2006, Epilepsia.
[51] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[52] C. Worby,et al. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[53] G. Avanzini,et al. Sensorimotor cortex excitability in Unverricht–Lundborg disease and Lafora body disease , 2004, Neurology.
[54] I Savic,et al. MRS shows syndrome differentiated metabolite changes in human-generalized epilepsies , 2004, NeuroImage.
[55] G Avanzini,et al. Movement-activated myoclonus in genetically defined progressive myoclonic epilepsies: EEG–EMG relationship estimated using autoregressive models , 2003, Clinical Neurophysiology.
[56] John S Duncan,et al. A Proton Magnetic Resonance Spectroscopy Study of Metabolites in the Occipital Lobes in Epilepsy , 2003, Epilepsia.
[57] D L Rothman,et al. Spectroscopic Assessment of Alterations in Macromolecule and Small-Molecule Metabolites in Human Brain After Stroke , 2001, Stroke.
[58] U Klose,et al. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. , 2001, Brain : a journal of neurology.
[59] S. A. Mayer,et al. Access www.neurology.org now for full-text articles , 2001, Neurology.
[60] V. Govindaraju,et al. Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.
[61] R Gruetter,et al. Extracellular–Intracellular Distribution of Glucose and Lactate in the Rat Brain Assessed Noninvasively by Diffusion-Weighted 1H Nuclear Magnetic Resonance Spectroscopy In Vivo , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[62] I Savic,et al. MR Spectroscopy Shows Reduced Frontal Lobe Concentrations of N‐Acetyl Aspartate in Patients with Juvenile Myoclonic Epilepsy , 2000, Epilepsia.
[63] Z. Meiner,et al. Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329 Ser mutation in the glycogen‐branching enzyme gene , 1998, Annals of neurology.
[64] R. Shulman,et al. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[65] M. Elzinga,et al. Nucleotide sequence of the fadA gene. Primary structure of 3-ketoacyl-coenzyme A thiolase from Escherichia coli and the structural organization of the fadAB operon. , 1990, The Journal of biological chemistry.
[66] Gonzalo R. Lafora,et al. Beitrag zur Histopathologie der myoklonischen Epilepsie , 1911 .
[67] C. Tassinari,et al. [Lafora disease (author's transl)]. , 1978, Revue d'electroencephalographie et de neurophysiologie clinique.